Results 311 to 320 of about 261,206 (349)

Sodium‐glucose cotransporter 2 inhibitors and outcomes in transthyretin amyloid cardiomyopathy: Systematic review and meta‐analysis

European Journal of Clinical Investigation, Volume 55, Issue 6, June 2025.
Patients with transthyretin amyloid cardiomyopathy (ATTR‐CM) were excluded from randomized clinical trials (RCTs) evaluating sodium‐glucose cotransporter 2 inhibitors (SGLT2i); as a result, the effects of these agents on this population remain underexplored.
Paschalis Karakasis, Panagiotis Theofilis, Dimitrios Patoulias, Art Schuermans, Panayotis K Vlachakis, Aleksandra Klisic, Manfredi Rizzo, Nikolaos Fragakis   +7 more
wiley   +1 more source

Implications of Associated Atrial Fibrillation in Brugada Syndrome for Sudden Cardiac Death ‒ A Case Series Analysis. [PDF]

Am J Case Rep
Iqbal M, Aditya Lesmana M, Putra ICS, Karwiky G, Achmad C, Goenawan H, Rizki Akbar M, Kartasasmita AS.   +7 more
europepmc   +1 more source

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation

European Journal of Clinical Investigation, EarlyView.
This consensus highlights critical research gaps in obesity epidemiology, phenotypic heterogeneity and clinical management, calling for advanced methodologies, collaborative strategies and innovative policies to mitigate the global obesity epidemic and its socio‐economic impacts.
Federico Carbone, Jean‐Pierre Després, John P. A. Ioannidis, Ian J. Neeland, Gabriella Garruti, Luca Busetto, Luca Liberale, Stefano Ministrini, Gemma Vilahur, Thomas H. Schindler, Maria Paula Macedo, Agostino Di Ciaula, Marcin Krawczyk, Andreas Geier, Gyorgy Baffy, Maria Felicia Faienza, Ilaria Farella, Nicola Santoro, Gema Frühbeck, Patricia Yárnoz‐Esquiroz, Javier Gómez‐Ambrosi, Emma Chávez‐Manzanera, Verónica Vázquez‐Velázquez, Jean‐Michel Oppert, Dimitrios N. Kiortsis, Paolo Sbraccia, Carmine Zoccali, Piero Portincasa, Fabrizio Montecucco   +28 more
wiley   +1 more source

Cost-Utility Analysis of LifeVest® in Post-Myocardial Infarction Patients at Risk of Sudden Cardiac Death in England. [PDF]

Pharmacoecon Open
Kontogiannis V, Goromonzi F, Both B, Semrau F, Branagan-Harris M, Atkinson J, Roberts PR, Javanbakht M.   +7 more
europepmc   +1 more source

The landscape of rare mitochondrial DNA variants in sudden cardiac death: A potential role for ATP synthase. [PDF]

Heliyon
Luppi E, De Luise M, Bini C, Pelletti G, Tioli G, Kurelac I, Iommarini L, Pelotti S, Gasparre G.   +8 more
europepmc   +1 more source

Autonomic dysfunction as a possible cause of sudden cardiac death in swimming sports. [PDF]

Front Cardiovasc Med
Dostal J, Hybska T, Saganelidze K, Pudil R, Stasek J.   +4 more
europepmc   +1 more source

Sudden cardiac death with morphologically normal heart: always do toxicology. [PDF]

J Clin Pathol
Radaelli D, Westaby J, Finocchiaro G, Sinagra G, D'Errico S, Sheppard MN.   +5 more
europepmc   +1 more source